Form 8-K - Current report:
SEC Accession No. 0001005286-24-000125
Filing Date
2024-08-26
Accepted
2024-08-26 17:26:20
Documents
14
Period of Report
2024-08-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20240826.htm   iXBRL 8-K 29598
2 EX-99.1 lfcrq4fy24earningsrelease.htm EX-99.1 390655
  Complete submission text file 0001005286-24-000125.txt   571950

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20240826.xsd EX-101.SCH 1983
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20240826_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20240826_pre.xml EX-101.PRE 12591
16 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20240826_htm.xml XML 2690
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0526
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 241242473
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)